Full name
VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. LUDWIKA WARYŃSKIEGO 3A, 00-645 WARSZAWA
TAX ID5252732188
Rate company:
VERTEX PHARMACEUTICALS (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5252732188
KRS0000705691
Share capital5,000.00 zł
address
UL. LUDWIKA WARYŃSKIEGO 3A, 00-645 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252732188
REGON
368940525
KRS
0000705691
Legal form
limited liability company
Register Address
UL. LUDWIKA WARYŃSKIEGO 3A, 00-645 WARSZAWA
Date of registration in KRS
2017-12-08
Date of commencement of economic activity
2017-12-08
Act signature
WA.XII NS-REJ.KRS/1805/24/898/ADE
Pkd codes
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL73 1030 1508 0000 0008 1878 4000 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,8 | 1,2 | 1,3 | 14,7 |
EBITDA | 0,8 | 1,2 | 1,4 | 15,5 |
Short time liabilities | 1,5 | 1,9 | 4,2 | 121,4 |
Equity capital | 1,2 | 1,9 | 2,8 | 47,8 |
Operating profit (EBIT) | 0,8 | 1,2 | 1,3 | 14,5 |
Assets | 4,1 | 5,6 | 8,9 | 59,2 |
Net profit (loss) | 0,2 | 0,7 | 0,9 | 23,3 |
Cash | 2 | 1,7 | 7,7 | 342,4 |
Liabilities and provisions for liabilities | 3 | 3,7 | 6,1 | 65,1 |
Net income from sale | 12 | 16,7 | 19,2 | 14,9 |
Working assets | 4,1 | 5,6 | 8,8 | 58,3 |
Depreciation | 0 | 0 | 0 | 122,4 |
% | % | % | p.p. | |
Profitability of capital | 18,8 | 38,8 | 32,3 | -6,5 |
Equity capital to total assets | 28,2 | 34,2 | 31,8 | -2,4 |
Gross profit margin | 6,8 | 6,9 | 6,9 | 0 |
EBITDA Margin | 7,1 | 7 | 7,1 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 41 | 79 | 38 |
Current financial liquidity indicator | 2.207811117172241 | 2.480274200439453 | 2.0053489208221436 | -0,5 |
Net dept to EBITDA | -2.3049778938293457 | -0.6968580484390259 | -4.791408538818359 | -4,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Grand - Med Janina Pławska
Racław
Gedeon Richter Polska sp. z o.o.
Grodzisk Mazowiecki
BEATA BOGDZIEWICZ AB-MED
Tychy
HS Medical Poland
Tychy